Addictions
Opioid seizures exploded by 3,000% in Ontario city after “safer supply” experiment
A London police drug seizure in April included 9,298 Dilaudid eight milligram tablets.
Doctors and journalists wondering why local police failed to disclose concerning statistic to public sooner
Nigel Stuckey saved more lives during the last five years of his policing career than the previous three decades combined. “Every time you go back to the street, it has a different flavour,” said Stuckey, a former sergeant with the London Police Service (LPS) who retired in 2022. “As a frontline police officer, you are constantly going to overdoses in the city. I’ve administered Narcan to multiple people, and this is just something that never existed before.”
Stuckey first noticed a dramatic increase in overdoses and drug-related crimes occurring throughout his city – London, Ontario – in 2019. While the reasons behind this increase were initially unclear, recent data released by the LPS suggest that “safer supply” programs may be contributing to the problem.
Safer supply programs aim to save lives by providing drug users with pharmaceutical-grade alternatives to the untested street supply. That typically means distributing hydromorphone, a heroin-strength opioid, as an alternative to illicit fentanyl. However, addiction experts say the program is having the opposite effect, as many people who are enrolled in safer supply programs are illegally selling or trading their prescribed hydromorphone on the black market, a practice known as “diversion.”
Harm reduction advocates claim that safer supply diversion is not a significant issue, but according to an investigation into London Police Services (LPS) seizure data by journalist Adam Zivo, the number of hydromorphone tablets seized in London increased by 3,000 per cent after access to safer supply was greatly expanded in 2020.
In 2019, the LPS seized fewer than 1,000 hydromorphone tablets. This number jumped significantly in 2020 and continued to rise afterwards, reaching 30,000 tablet seizures last year – an unprecedented amount. The London police estimate that last year’s record will be met or exceeded by the end of 2024.
Doctors have said that this is only representative of a small fraction of what is actually out there, and that just 3-4 of these pills, if snorted, are enough to induce an overdose in a new user.
Some people are wondering why this data wasn’t released months, if not years, earlier.
Dr. Sharon Koivu, a London-based addiction physician, was among the first to recognize the harms of safer supply and has been warning the public about widespread diversion for years. Based on her clinical experiences, she believes that diverted safer supply hydromorphone is causing new addictions and falling into the hands of youth.
When Koivu tried to speak out against safer supply and call attention to diversion and an overall lack of program transparency, she was bullied and told that the suffering she was witnessing didn’t exist. This harassment was so severe that her mental health deteriorated and she worried about whether her career had been irreversibly damaged – yet the London police had quietly possessed data showing that she was right all along.
“It’s become an ideological thing,” she said. “People seem to have doubled down on the information they have. They don’t want to hear from someone who has information and concerns that don’t align with their, I’m going to say, ideology – because it’s not science.”
News of skyrocketing hydromorphone seizures might have remained hidden from the public had it not been for a major bust earlier this year.
Subscribe to our newsletter to get our latest news and analysis – or donate to our investigative journalism fund.
On April 12, the London police announced a drug seizure which included 9,298 hydromorphone eight-milligram tablets. When Zivo inquired into this seizure, he received no answers to his questions for almost two months. He says that he was “stonewalled” and that the police seemed unwilling to release key data until it became impossible for them not to.
Zivo found it particularly concerning that the 2019-2023 hydromorphone seizure data was not released earlier. “Journalists and addiction physicians have been trying to raise the alarm about this issue for years,” he said, “but have been called liars, grifters and fearmongers, despite the fact that data validating their concerns existed and was held by the London Police Service.”
Stuckey, who now works as a documentary filmmaker covering London’s homelessness, addiction and mental health crisis, had a similar experience when he queried the LPS about the 9,290 hydromorphone pills seized this April.
Despite multiple requests for information about a possible connection to safer supply, the police service did not get back to him. He expressed frustration at the police’s unresponsiveness and worried that a lack of government transparency is endangering both the general public and law enforcement officers.
“Members of the London Police Service are being put in harm’s way dealing with organized crime and firearms to take drugs off the street, which were provided by the federal government. It’s absolute lunacy that we are paying one branch of government to rid a problem that was created by another branch of government,” said Stuckey.
It would be deeply concerning if the LPS knowingly withheld data pertaining to safer supply diversion. Not only has the failure to publish such data hindered informed public debate and policy development, it has also compromised the safety of the very communities which police are tasked with protecting.
According to Zivo, safer supply programs have benefitted from the silence of powerful institutions like the LPS. He said that, as there seems to be significant institutional resistance to acknowledging the community harms of safer supply, then more attention and trust should be given to local grassroots-level addiction medicine practitioners “who are bravely testifying to what they are seeing in their clinics.”
However, Dr. Koivu thinks that “the tide is turning” and that more people are beginning to understand the harms of safer supply
“I think it’s unfortunate that this data wasn’t made available sooner, when it was relevant to the funding of these programs and the changes we’re seeing in the city. The police need to be accountable for that. I really don’t understand their rationale for not addressing this” she said. “They hung me out to dry while knowing that what I was saying was accurate. If the police are afraid to come forward, no wonder physicians are afraid to come forward, too.”
![]() |
A guest post by
|
Addictions
Activists Claim Dealers Can Fix Canada’s Drug Problem
By Adam Zivo
We should learn from misguided experiments with activist-driven drug ideologies.
Some Canadian public-health researchers have argued that the nation’s drug dealers, far from being a public scourge, are central to the cause of “harm reduction,” and that drug criminalization makes it harder for them to provide this much-needed “mutual aid.” Incredibly, these ideas have gained traction among Canada’s policymakers, and some have even been put into practice.
Gillian Kolla, an influential harm-reduction activist and researcher, spearheaded the push to whitewash drug trafficking in Canada. Over the past decade, she has advocated for many of the country’s failed laissez-faire drug policies. In her 2020 doctoral dissertation, she described her hands-on research into Toronto’s “harm reduction satellite sites”—government-funded programs that paid drug users to provide services out of their homes.
The sites Kolla studied were operated by the nonprofit South Riverdale Community Health Centre (SRCHC) in Toronto. Addicts participating in the programs received $250 per month in exchange for distributing naloxone and clean paraphernalia (needles and crack pipes, for example), as well as for reversing overdoses and educating acquaintances on safer consumption practices. At the time of Kolla’s research (2016–2017), the SRCHC was operating nine satellite sites, which reportedly distributed about 1,500 needles and syringes per month.
Canada permits supervised consumption sites—facilities where people can use drugs under staff oversight—to operate so long as they receive an official exemption via the federal Controlled Drugs and Substances Act. As the sites Kolla observed did not receive exemptions, they were certainly illegal. Kolla herself acknowledged this in her dissertation, writing that she, with the approval of the University of Toronto, never recorded real names or locations in her field notes, in case law enforcement subpoenaed her research data.
Even so, the program seems to have enjoyed the blessing of Toronto’s public health officials and police. The satellite sites received local funding from 2010 onward, after a decade of operating on a volunteer basis, apparently with special protection from law enforcement. In her dissertation, Kolla described how SRCHC staff trained police officers to leave their sites alone, and how satellite-site workers received special ID badges and plaques to ward off arrest.
Kolla made it clear that many of these workers were not just addicts but dealers, too, and that tolerance of drug trafficking was a “key feature” of the satellite sites. She even described, in detail, how she observed one of the site workers packaging and selling heroin alongside crackpipes and needles.
In her dissertation, Kolla advocated expanding this permissive approach. She claimed that traffickers practice harm reduction by procuring high-quality drugs for their customers and avoiding selling doses that are too strong.
“Negative framings of drug selling as predatory and inherently lacking in care make it difficult to perceive the wide variety of acts of mutual aid and care that surround drug buying and selling as practices of care,” she wrote.
In truth, dealers routinely sell customers tainted or overly potent drugs. Anyone who works in the addiction field can testify that this is a major reason that overdose deaths are so common.
Ultimately, Kolla argued that “real harm reduction” should involve drug traffickers, and that criminalization creates “tremendous barriers” to this goal.
The same year she published her dissertation, Kolla cowrote a paper in the Harm Reduction Journal with her Ph.D. supervisor at the Dalla Lana School of Public Health. The article affirmed the view that drug traffickers are essential to the harm-reduction movement. Around this time, the SRCHC collaborated with the Toronto-based Parkdale Queen West Community Health Centre— the only other organization running such sites—to produce guidelines on how to replicate and scale up the experiment.
Thankfully, despite its local adoption, this idea did not catch on at the national level. It was among the few areas in the early 2020s where Canada did not fully descend into addiction-enabling madness. Yet, like-minded researchers still echo Kolla’s work.
In 2024, for example, a group of American harm-reduction advocates published a paper in Drug and Alcohol Dependence Reports that concluded, based on just six interviews with drug traffickers in Indianapolis, that dealers are “uniquely positioned” to provide harm-reduction services, partly because they are motivated by “the moral imperative to provide mutual aid.” Among other things, the authors argued that drug criminalization is harmful because it removes dealers from their social networks and prevents them from enacting “community-based practices of ethics and care.”
It’s instructive to review what ultimately happened with the originators of this movement—Kolla and the SRCHC. Having failed to whitewash drug trafficking, Kolla moved on to advocating for “safer supply”—an experimental strategy that provides addicts with free recreational drugs to dissuade use of riskier street substances. The Canadian government funded and expanded safer supply, thanks in large part to Kolla’s academic work. It abandoned the experiment after news broke that addicts resell their safer supply on the black market to buy illicit fentanyl, flooding communities with diverted opioids and fueling addiction.
The SRCHC was similarly discredited after a young mother, Karolina Huebner-Makurat, was shot and killed near the organization’s supervised consumption site in 2023. Subsequent media reports revealed that the organization had effectively ignored community complaints about public safety, and that staff had welcomed, and even supported, drug traffickers. One of the SRCHC’s harm-reduction workers was eventually convicted of helping Huebner-Makurat’s shooter evade capture by hiding him from the police in an Airbnb apartment and lying to the police.
There is no need for policymakers to repeat these mistakes, or to embrace its dysfunctional, activist-driven drug ideologies. Let this be another case study of why harm-reduction policies should be treated with extreme skepticism.
Our content is always free
If you want to help us commission more high-quality journalism,
consider getting a voluntary paid subscription.
Addictions
Canadian gov’t not stopping drug injection sites from being set up near schools, daycares
From LifeSiteNews
Canada’s health department told MPs there is not a minimum distance requirement between safe consumption sites and schools, daycares or playgrounds.
So-called “safe” drug injection sites do not require a minimum distance from schools, daycares, or even playgrounds, Health Canada has stated, and that has puzzled some MPs.
Canadian Health Minister Marjorie Michel recently told MPs that it was not up to the federal government to make rules around where drug use sites could be located.
“Health Canada does not set a minimum distance requirement between safe consumption sites and nearby locations such as schools, daycares or playgrounds,” the health department wrote in a submission to the House of Commons health committee.
“Nor does the department collect or maintain a comprehensive list of addresses for these facilities in Canada.”
Records show that there are 31 such “safe” injection sites allowed under the Controlled Drugs And Substances Act in six Canadian provinces. There are 13 are in Ontario, five each in Alberta, Quebec, and British Columbia, and two in Saskatchewan and one in Nova Scotia.
The department noted, as per Blacklock’s Reporter, that it considers the location of each site before approving it, including “expressions of community support or opposition.”
Michel had earlier told the committee that it was not her job to decide where such sites are located, saying, “This does not fall directly under my responsibility.”
Conservative MP Dan Mazier had asked for limits on where such “safe” injection drug sites would be placed, asking Michel in a recent committee meeting, “Do you personally review the applications before they’re approved?”
Michel said that “(a)pplications are reviewed by the department.”
Mazier stated, “Are you aware your department is approving supervised consumption sites next to daycares, schools and playgrounds?”
Michel said, “Supervised consumption sites were created to prevent overdose deaths.”
Mazier continued to press Michel, asking her how many “supervised consumption sites approved by your department are next to daycares.”
“I couldn’t tell you exactly how many,” Michel replied.
Mazier was mum on whether or not her department would commit to not approving such sites near schools, playgrounds, or daycares.
An injection site in Montreal, which opened in 2024, is located close to a kindergarten playground.
Conservative Party leader Pierre Poilievre has called such sites “drug dens” and has blasted them as not being “safe” and “disasters.”
Records show that the Liberal government has spent approximately $820 million from 2017 to 2022 on its Canadian Drugs and Substances Strategy. However, even Canada’s own Department of Health admitted in a 2023 report that the Liberals’ drug program only had “minimal” results.
Recently, LifeSiteNews reported that the British Columbia government decided to stop a so-called “safe supply” free drug program in light of a report revealing many of the hard drugs distributed via pharmacies were resold on the black market.
British Columbia Premier David Eby recently admitted that allowing the decriminalization of hard drugs in British Columbia via a federal pilot program was a mistake.
Former Prime Minister Justin Trudeau’s loose drug initiatives were deemed such a disaster in British Columbia that Eby’s government asked Trudeau to re-criminalize narcotic use in public spaces, a request that was granted.
Official figures show that overdoses went up during the decriminalization trial, with 3,313 deaths over 15 months, compared with 2,843 in the same time frame before drugs were temporarily legalized.
-
Alberta2 days agoAlberta on right path to better health care
-
Crime2 days ago‘Modern-Day Escobar’: U.S. Says Former Canadian Olympian Ran Cocaine Pipeline with Cartel Protection and a Corrupt Toronto Lawyer
-
Business1 day agoCanada is failing dismally at our climate goals. We’re also ruining our economy.
-
Alberta2 days agoAlberta Emergency Alert test – Wednesday at 1:55 PM
-
Health17 hours agoCDC’s Autism Reversal: Inside the Collapse of a 25‑Year Public Health Narrative
-
Alberta2 days agoCarney government’s anti-oil sentiment no longer in doubt
-
Artificial Intelligence1 day agoLawsuit Claims Google Secretly Used Gemini AI to Scan Private Gmail and Chat Data
-
Alberta1 day agoAlberta to protect three pro-family laws by invoking notwithstanding clause






